Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00944346 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects
A Phase 1 study, sponsored by Torrent Pharmaceuticals Limited.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00944346: Completed Phase 1 study, sponsored by Torrent Pharmaceuticals Limited.
NCT00944346 is a Phase 1 study that has completed, run by Torrent Pharmaceuticals Limited. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00944346, a Phase 1 study, has completed, sponsored by Torrent Pharmaceuticals Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
* Objective: * A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects. * Study Design: * Randomized,single-dose,2-way crossover.
Interventions
- DRUG Metformin HCl
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00944346 record still lists
NCT00944346 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Metformin HCl is the first listed.
NCT00944346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00944346 about?
NCT00944346 is a clinical study titled "Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects". * Objective: * A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fa...
What is the current status of trial NCT00944346?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00944346?
The interventions under investigation include: Metformin HCl (DRUG).
Who is sponsoring clinical trial NCT00944346?
This trial is sponsored by Torrent Pharmaceuticals Limited, which has 7 total clinical trials registered on ClinicalTrials.gov.